Coulie Bernard — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Coulie Bernard has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $114K.

Profile

Coulie Bernard

Coulie Bernard is listed in SEC filings as the President and Chief Executive Officer of Pliant Therapeutics, Inc. as of April 17, 2026. Pliant Therapeutics is a publicly traded biotechnology company focused on developing therapies for fibrotic diseases. Based on the provided SEC context, Bernard is the senior executive responsible for the strategic direction and overall management of the company. No additional verified biographical details are included in the provided context.

RoleInsider
Notability60/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-01-23PLRXPLIANT THERAPEUTICS, INC.S — Open-market sale [10b5-1]89.4K$1.28$114K

Companies — Last 90 Days

Frequently Asked Questions

Who is Coulie Bernard?

Coulie Bernard is listed in SEC filings as the President and Chief Executive Officer of Pliant Therapeutics, Inc. as of April 17, 2026. Pliant Therapeutics is a publicly traded biotechnology company focused on developing therapies for fibrotic diseases. Based on the provided SEC context, Bernard is the senior executive responsible for the strategic direction and overall managem…

How many SEC Form 4 filings has Coulie Bernard submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Coulie Bernard been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($114K) across all tracked filings.

Where can I see all of Coulie Bernard's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Coulie Bernard profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.